LH Relative Valuation
LH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LH is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for LH's competitors is 2.08, providing a benchmark for relative valuation. Laboratory Corporation of America Holdings Corp (LH) exhibits a P/S ratio of 1.49, which is -28.54% above the industry average. Given its robust revenue growth of 5.30%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Laboratory Corporation of America Holdings (LH) currently overvalued or undervalued?
What is Laboratory Corporation of America Holdings (LH) fair value?
How does LH's valuation metrics compare to the industry average?
What is the current P/B ratio for Laboratory Corporation of America Holdings (LH) as of May 19 2025?
What is the current FCF Yield for Laboratory Corporation of America Holdings (LH) as of May 19 2025?
What is the current Forward P/E ratio for Laboratory Corporation of America Holdings (LH) as of May 19 2025?